Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mild to moderate pain Protocol: BPC-157: 250mcg twice daily Duration: 4-8 weeks Method: Injectable near pain site or systemic Expected outcome: 40-60% pain reduction Improved function May be sufficient alone Severe or chronic pain Protocol: BPC-157: 500mcg twice daily TB-500: 5-10mg weekly loading for 4-6 weeks, then 2-5mg maintenance Duration: 12-16 weeks minimum Method: Injectable Expected outcome: 50-70% pain reduction Significant functional improvement Better quality of life Multiple pain sites or systemic pain Protocol: BPC-157: 250-500mcg twice daily (systemic injections - abdomen/thighs) TB-500: 5mg weekly Optional: KPV 500mcg daily if inflammation major factor Duration: 12-24 weeks Expected outcome: 40-60% overall pain reduction Improved multiple areas Better mobility Maintenance protocol After initial relief: BPC-157: 250mcg daily OR every other day TB-500: 2-5mg weekly OR biweekly Duration: Ongoing as needed Why maintenance: Prevents pain return Continues healing Safe long-term Use our peptide dosing guide , peptide dosage chart , and how to calculate peptide dosages
Heres what helps most: Protein at every meal and snack
August 19, 2025: Judge in Ozempic Lawsuits Rules on Medical Tests Required for Plaintiffs Claiming Gastroparesis Many people who have joined the federal group lawsuit for those harmed by Ozempic have said the drug caused their gastroparesis
Microdosing means using a much smaller dose of a GLP-1 medication than whats typically prescribed for diabetes or weight loss often a fraction of the standard starting dose
But you may feel like youve lost any positive effects alcohol had on you before taking a GLP-1 drug
